Urinary N-terminal B-type natriuretic peptide predicts severe retinopathy of prematurity

Pediatrics

Volumn 128, Issue 3, 2011, Pages

  Czernik, Christoph ^a   Metze, Boris ^a   Müller, Christian ^a   Müller, Bert ^a   Bührer, Christoph ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bronchopulmonary dysplasia; Newborn infant; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; OXYGEN;

ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE SEVERITY; EYE EXAMINATION; FEMALE; GESTATIONAL AGE; HIGH RISK INFANT; HOSPITAL DISCHARGE; HUMAN; INFANT; LONGITUDINAL STUDY; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEWBORN; OXYGEN THERAPY; PREDICTION; PREDICTIVE VALUE; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; RETINA SURGERY; RETROLENTAL FIBROPLASIA; SENSITIVITY AND SPECIFICITY; VERY LOW BIRTH WEIGHT;

BIRTH WEIGHT; BRONCHOPULMONARY DYSPLASIA; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; NATRIURETIC PEPTIDE, BRAIN; RETINOPATHY OF PREMATURITY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 80052348372     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-0603     Document Type: Article

References (27)

1. Nir A., Bar-Oz B., Perles Z., Brooks R., Korach A., Rein A.J. N-terminal pro-B-type natriuretic peptide: Reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr. 2004;93(5):603-607 (Pubitemid 38570224)
2. El-Khuffash A., Barry D., Walsh K., Davis P.G., Molloy E.J. Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage. Arch Dis Child Fetal Neonatal Ed. 2008;93(6):F407-F412
3. El-Khuffash A.F., Amoruso M., Culliton M., Molloy E.J. N-terminal pro-B-type natriuretic peptide as a marker of ductal haemodynamic significance in preterm infants: A prospective observational study. Arch Dis Child Fetal Neonatal Ed. 2007;92(5):F421-F422 (Pubitemid 47436237)
4. Farombi-Oghuvbu I., Matthews T., Mayne P.D., Guerin H., Corcoran J.D. N-terminal pro-Btype natriuretic peptide: A measure of significant patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 2008;93(4):F257-F260 (Pubitemid 352039393)
5. Joseph L., Nir A., Hammerman C., Goldberg S., Ben Shalom E., Picard E. N-terminal pro-Btype natriuretic peptide as a marker of bronchopulmonary dysplasia in premature infants. Am J Perinatol. 2010;27(5):381-386
6. The CRIB (clinical risk index for babies) score: A tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. The International Neonatal Network. Lancet. 1993;342:193-198
7. Thébaud B., Abman S.H. Bronchopulmonary dysplasia: Where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med. 2007;175(10):978-985 (Pubitemid 46741748)
8. Hayes D. Jr, Feola D.J., Murphy B.S., Shook L.A., Ballard H.O. Pathogenesis of bronchopulmonary dysplasia. Respiration. 2010;79(5):425-436
9. Sapieha P., Joyal J.S., Rivera J.C., et al. Retinopathy of prematurity: Understanding ischemic retinal vasculopathies at an extreme of life. J Clin Invest. 2010;120(9):3022-3032
10. Laughon M., Allred E.N., Bose C., et al. Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics. 2009;123(4):1124-1131
11. Pedram A., Razandi M., Levin E.R. Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis. Endocrinology. 2001;142(4):1578-1586 (Pubitemid 32299687)
12. Lara-Castillo N., Zandi S., Nakao S., et al. Atrial natriuretic peptide reduces vascular leakage and choroidal neovascularization. Am J Pathol. 2009;175(6):2343-2350
13. Salzmann J., Flitcroft D., Bunce C., Gordon D., Wormald R., Migdal C. Brain natriuretic peptide: Identification of a second natriuretic peptide in human aqueous humour. Br J Ophthalmol. 1998;82(7):830-834 (Pubitemid 28376919)
14. Rollín R., Mediero A., Roldán-Pallarés M., Fernández-Cruz A., Fernández-Durango R. Natriuretic peptide system in the human retina. Mol Vis. 2004;10:15-22 (Pubitemid 38628982)
15. Katoli P., Sharif N.A., Sule A., Dimitrijevich S.D. NPR-B natriuretic peptide receptors in human corneal epithelium: MRNA, immunohistochemistochemical, protein, and biochemical pharmacology studies. Mol Vis. 2010;16:1241-1252
16. O'Sullivan A., O'Connor M., Brosnahan D., Mc-Creery K., Dempsey E.M. Sweeten, soother and swaddle for retinopathy of prematurity screening: A randomised placebo controlled trial. Arch Dis Child Fetal Neonatal Ed. 2010;95(6):F419-F422
17. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2006;117(2):572-576
18. Hered R.W., Gyland E.A. The retinopathy of prematurity screening examination: Ensuring a safe and efficient examination while minimizing infant discomfort. Neonatal Netw. 2010;29:143-151
19. Rush R., Rush S., Nicolau J., Chapman K., Nagvi M. Systemic manifestations in response to mydriasis and physical examination during screening for retinopathy of prematurity. Retina. 2004;24:242-245 (Pubitemid 38509611)
20. Hoogerwerf A., Schalij-Delfos N.E., Van Schooneveld M.J., Termote J.U. Incidence of retinopathy of prematurity over the last decade in the Central Netherlands. Neonatology. 2010;98(2):137-142
21. Fortes Filho J.B., Eckert G.U., Valiatti F.B., Dos Santos P.G., Da Costa M.C., Procianoy R.S. The influence of gestational age on the dynamic behavior of other risk factors associated with retinopathy of prematurity (ROP). Graefes Arch Clin Exp Ophthalmol. 2010;248(6):893-900
22. Yang M.B., Donovan E.F. Risk analysis and an alternative protocol for reduction of screening for retinopathy of prematurity. J AAPOS. 2009;13(6):539-545
23. Durnian J.M., Clark D.I. Retinopathy of prematurity: Keeping the status quo. A case series detailing the importance of keeping the current guidelines for screening. Br J Ophthalmol. 2010;94(12):1693-1694
24. Basmak H., Niyaz L., Sahin A., Erol N., Gürsoy H.H. Retinopathy of prematurity: Screening guidelines need to be reevaluated for developing countries. Eur J Ophthalmol. 2010;20(4):752-755
25. Hellström A., Ley D., Hansen-Pupp I., et al. New insights into the development of retinopathy of prematurity - Importance of early weight gain. Acta Paediatr. 2010;99(4):502-508
26. Wu C., Vanderveen D.K., Hellström A., Löfqvist C., Smith L.E. Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity. Arch Ophthalmol. 2010;128(4):443-447
27. Hård A.L., Lömaifqvist C., Fortes Filho J.B., Procianoy R.S., Smith L., Hellström A. Predicting proliferative retinopathy in a Brazilian population of preterm infants with the screening algorithm WINROP. Arch Ophthalmol. 2010;128(11):1432-1436